NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results

Share this story with your network

– Fourth Quarter Revenue of $74.6 Million –

– 2008 Revenue of $250.1 Million –

– Provides 2009 Guidance –

Fourth Quarter and Full Year 2008 Highlights:

– Fourth quarter total revenue of $74.6 million; up 58.9% from the fourth quarter 2007

– Full year 2008 total revenue of $250.1 million; up 62.1% from the full year 2007

– Osteocel revenue for the second half 2008 of $10 million; exceeds prior guidance of $9 million

– Gross margin of 82.0% for the fourth quarter and 82.3% for the full year

– GAAP earnings per share was $0.10 for the fourth quarter and loss per share was $(0.77) for the full year

– Full year 2008 earnings per share of $0.10 excluding in-process research and development costs and other adjustments; exceeds prior guidance of $0.07 – $0.09

Leave a Comment

Your email address will not be published. Required fields are marked *

*